Loading clinical trials...
Loading clinical trials...
Evaluating the Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts: The RETRIEVE Study
Conditions
Interventions
FiberNet EPS used during SVG intervention.
Locations
6
United States
Munroe Regional Medical Center
Ocala, Florida, United States
St. Vincent Hospital
Indianapolis, Indiana, United States
William Beaumont Hospital
Royal Oak, Michigan, United States
Christ Hospital
Cincinnati, Ohio, United States
Riverside Methodist Hospital
Columbus, Ohio, United States
Lehigh Valley Hospital
Allentown, Pennsylvania, United States
Start Date
March 1, 2007
Primary Completion Date
February 1, 2009
Completion Date
February 1, 2009
Last Updated
August 18, 2009
NCT06183944
NCT05963698
NCT06189313
NCT07015905
NCT03728166
NCT07102160
Lead Sponsor
Lumen Biomedical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions